Sphingomyelin synthase 2 over-expression induces expression of aortic inflammatory biomarkers and decreases circulating EPCs in ApoE KO mice

Life Sciences

Volumn 90, Issue 21-22, 2012, Pages 867-873

  Zhao, Ya Rui ^a   Dong, Ji Bin ^a   Li, Yue ^a   Wu, Man Ping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Endothelial progenitor cells (EPC); Inflammatory biomarkers; Over expression; Plaque instability; Sphingomyelin synthase 2 (SMS2)

Indexed keywords

ADENOVIRUS VECTOR; BIOLOGICAL MARKER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GELATINASE A; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SPHINGOMYELIN SYNTHASE 2; SYNTHETASE; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; INFLAMMATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PLAQUE, ATHEROSCLEROTIC; STEM CELLS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

ADENOVIRIDAE; MUS;

EID: 84861576340     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.04.003     Document Type: Article

References (45)

1. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, and T. Li Isolation of putative progenitor endothelial cells for angiogenesis Science 275 5302 1997 964 967
2. V. Ashok, C. Dash, T.E. Rohan, J.M. Sprafka, and P.D. Terry Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk Breast 20 1 2011 66 70
3. S. Brunner, G.H. Schernthaner, M. Satler, M. Elhenicky, F. Hoellerl, and K.E. Schmid-Kubista Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data Invest Ophthalmol Vis Sci 50 1 2009 392 398
4. M.J. Davies Apoptosis in cardiovascular disease Heart 77 6 1997 498 501
5. M.J. Davies, and A. Thomas Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death N Engl J Med 310 18 1984 1137 1140
6. T. Ding, Z. Li, T. Hailemariam, S. Mukherjee, F.R. Maxfield, and M.P. Wu SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis J Lipid Res 49 2 2008 376 385
7. J. Dong, J. Liu, B. Lou, Z. Li, X. Ye, and M.P. Wu Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice J Lipid Res 47 6 2006 1307 1314
8. J.F. Fisher, and S. Mobashery Mechanism-based profiling of MMPs Methods Mol Biol 622 2010 471 487
9. B. Glowinska-Olszewska, W. Luczynski, and A. Bossowski Endothelial progenitor cells as a new marker of endothelial function with respect to risk of cardiovascular disorders Postepy Hig Med Dosw (Online) 65 2011 8 15
10. M. Gomaraschi, L. Calabresi, G. Rossoni, S. Iametti, G. Franceschini, and J.A. Stonik Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides J Pharmacol Exp Ther 324 2 2008 776 783
11. T.K. Hailemariam, C. Huan, J. Liu, Z. Li, C. Roman, and M. Kalbfeisch Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation Arterioscler Thromb Vasc Biol 28 2008 1519 1526
12. S.H. Heo, C.H. Cho, H.O. Kim, Y.H. Jo, K.S. Yoon, and J.H. Lee Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9 J Clin Neurol 7 2 2011 69 76
13. J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, and A.A. Quyyumi Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 7 2003 593 600
14. W. Hort Arteriosclerotic plaque rupture. Its significance for myocardial infarct, sudden heart death and unstable angina Versicherungsmedizin 43 5 1991 151 154
15. K. Huitema, J. van den Dikkenberg, J.F. Brouwers, and J.C. Holthuis Identification of a family of animal sphingomyelin synthases EMBO J 23 1 2004 33 44
16. X.C. Jiang, F. Paultre, T.A. Pearson, R.G. Reed, C.K. Francis, and M. Lin Plasma sphingomyelin level as a risk factor for coronary artery disease Arterioscler Thromb Vasc Biol 20 12 2000 2614 2618
17. V. Jodon de Villeroche, J. Avouac, A. Ponceau, B. Ruiz, A. Kahan, and C. Boileau Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity Arthritis Res Ther 12 1 2010 R27
18. E. Kaluski, A. Waller, A. Patel, C. Gerula, J. Maher, and B. Haider Clinical applicability of coronary atherosclerotic lesion characterization Minerva Cardioangiol 59 3 2011 255 270
19. D. Kogure, T. Iwamoto, and M. Takasaki Aging and ultrasonographic findings of carotid atherosclerosis Nippon Ronen Igakkai Zasshi 34 7 1997 560 568
20. F.D. Kolodgie, R. Virmani, A.P. Burke, A. Farb, D.K. Weber, and R. Kutys Pathologic assessment of the vulnerable human coronary plaque Heart 90 12 2004 1385 1391
21. J. Liu, H. Zhang, Z. Li, T.K. Hailemariam, M. Chakraborty, and K. Jiang Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice Arterioscler Thromb Vasc Biol 29 6 2009 850 856
22. B.A. Lwaleed, A.J. Cooper, D. Voegeli, and K. Getliffe Tissue factor: a critical role in inflammation and cancer Biol Res Nurs 9 2 2007 97 107
23. T. Matsumoto, E. Saito, H. Watanabe, T. Fujioka, T. Yamada, and Y. Takahashi Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits Atherosclerosis 139 1 1998 95 106
24. S. McClelland, M. Gawaz, E. Kennerknecht, C.S. Konrad, S. Sauer, and K. Schuerzinger Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse Atherosclerosis 202 1 2009 84 91
25. A. Meng, C. Luberto, P. Meie, A. Bai, X. Yang, and Y.A. Hannun Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells Exp Cell Res 292 2 2004 385 392
26. A.H. Merrill Jr., and D.D. Jones An update of the enzymology and regulation of sphingomyelin metabolism Biochim Biophys Acta 1044 1 1990 1 12
27. T. Murayama, O.M. Tepper, M. Silver, H. Ma, D.W. Losordo, and J.M. Isner Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo Exp Hematol 30 8 2002 967 972
28. K. Musial, and D. Zwolinska Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment Cell Stress Chaperones 16 1 2011 97 103
29. J. Odenbach, X. Wang, S. Cooper, F.L. Chow, T. Oka, and G. Lopaschuk MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE Hypertension 57 1 2011 123 130
30. V.O. Puntmann, B. Bigalke, and E. Nagel Characterization of the inflammatory phenotype in atherosclerosis may contribute to the development of new therapeutic and preventative interventions Trends Cardiovasc Med 20 5 2010 176 181
31. F.M. Rauscher, P.J. Goldschmidt-Clermont, B.H. Davis, T. Wang, D. Gregg, and P. Ramaswami Aging, progenitor cell exhaustion, and atherosclerosis Circulation 108 4 2003 457 463
32. K.J. Reddy, M. Singh, J.R. Bangit, and R.R. Batsell The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review J Clin Lipidol 3 2 2009 85 93
33. J. Rehman, J. Li, C.M. Orschell, and K.L. March Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 8 2003 1164 1169
34. M.K. Reriani, S.M. Dunlay, B. Gupta, C.P. West, C.S. Rihal, and L.O. Lerman Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials Eur J Cardiovasc Prev Rehabil 18 5 2011 704 716
35. Z.M. Ruggeri Platelets in atherothrombosis Nat Med 8 11 2002 1227 1234
36. A. Schlitt, S. Blankenberg, D. Yan, H. Von Gizycki, M. Buerke, and K. Werdan Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease Nutr Metab (Lond) 3 2006 5 12
37. C. Schmidt-Lucke, S. Fichtlscherer, A. Aicher, C. Tschope, H.P. Schultheiss, and A.M. Zeiher Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol PLoS One 5 11 2010 e13790
38. B.A. Steppich, S.L. Braun, A. Stein, G. Demetz, P. Groha, and A. Schomig Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction Thromb J 7 2009 11 18
39. J.L. Van Herck, D.M. Schrijvers, G.R. De Meyer, W. Martinet, C.E. Van Hove, and H. Bult Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice J Vasc Res 47 3 2010 231 240
40. M. Vasa, S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich, and H. Martin Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 89 1 2001 E1 E7
41. R.E. Verloop, P. Koolwijk, A.J. van Zonneveld, and V.W. van Hinsbergh Proteases and receptors in the recruitment of endothelial progenitor cells in neovascularization Eur Cytokine Netw 20 4 2009 207 219
42. X. Wang, J. Dong, Y. Zhao, Y. Li, and M. Wu Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice Lipids Health Dis 10 2011 7 12
43. T.S. Worgall Sphingolipids: major regulators of lipid metabolism Curr Opin Clin Nutr Metab Care 10 2 2007 149 155
44. A. Yadav, V. Saini, and S. Arora MCP-1: chemoattractant with a role beyond immunity: a review Clin Chim Acta 411 21-22 2010 1570 1579
45. N. Yan, T. Ding, J. Dong, Y. Li, and M. Wu Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells Lipids Health Dis 10 1 2011 46 52